Astrazeneca (AZN) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Powered by 
Analysis
Astrazeneca (AZN) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.04 Bn | 602.06 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 362.64 Bn | 362.64 Bn | - | - |
| 3 | General Electric | 329.87 Bn | 320.52 Bn | 6.95 Bn | 359.15% |
| 4 | Astrazeneca | 253.67 Bn | 248.39 Bn | 12.86 Bn | 11.31% |
| 5 | Citigroup | 228.64 Bn | -2,073.66 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.08 Bn | 197.54 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - | - |
| 9 | Unilever | 139.34 Bn | 132.31 Bn | - | - |
| 10 | Hdfc Bank | 117.87 Bn | 80.72 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.31% |
| Mar 31, 2026 | 19.54% |
| Dec 31, 2025 | 37.18% |
| Sep 30, 2025 | 15.59% |
| Jun 30, 2025 | 89.51% |
| Mar 31, 2025 | 96.22% |
| Dec 31, 2024 | 79.15% |
| Sep 30, 2024 | 84.99% |
| Jun 30, 2024 | 51.88% |
| Mar 31, 2024 | 11.76% |
| Dec 31, 2023 | 1.10% |
| Sep 30, 2023 | 46.39% |
| Jun 30, 2023 | 39.00% |
| Mar 31, 2023 | 32.22% |
| Dec 31, 2022 | 20.34% |
| Sep 30, 2022 | 70.48% |
| Jun 30, 2022 | 40.43% |
| Mar 31, 2022 | -13.33% |
| Dec 31, 2021 | 11.70% |
| Sep 30, 2021 | -78.52% |